Financial Advisor
A&E Medical Corporation
M&A Advisory
A Portfolio Company Of
Has Been Acquired By
Transaction Details
- On December 1, 2020, Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) announced that the company had completed the acquisition of A&E Medical Corporation (“A&E Medical”), a Vance Street Capital Portfolio Company, for $250 million
- Zimmer Biomet has acquired A&E Medical and its complete portfolio of sternal closure devices – including sternal sutures, cable systems and rigid fixation – along with a range of single-use complementary temporary pacing wire and surgical punch products
- Zimmer Biomet will pay $150 million in cash at closing and $100 million in cash payable in 2021
About the company
A&E Medical
Founded in 1968 and headquartered in Farmingdale, NJ, A&E Medical is a leading designer and manufacturer of a comprehensive portfolio of sternal closure devices including A&E DoubleWire™, the A&E Medical® Sternal Cable System, and the Thorecon® and Tritium® rigid fixation systems; along with a wide variety of temporary cardiac pacing wires including the MYO/Wire® Ultra-Thin and MYO/Wire® Ultra-Flex brands, disposable patient cables, and A&E Medical® Surgical Punch. A&E Medical was acquired by Vance Street Capital in 2016.
Vance Street Capital
Vance Street Capital is a middle-market private equity firm focused on investing in highly engineered solutions businesses across the medical, aerospace, defense and industrial sectors. For over two decades, Vance Street’s partners have worked with management teams and family owners to accelerate revenue growth, improve operations and acquire strategic assets for the companies in their investment portfolio.
Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, IN, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Sources: Press releases, public filings and other publicly available information.
-
This material has been prepared solely for informative purposes as of its stated date and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from sources which we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. No subsequent publication or distribution of this material shall mean or imply that any such information or opinion remains current at any time after the stated date of the material. We do not undertake to advise you of any changes in any such information or opinion. Additional information is available upon request.
“Stephens” is the brand name for a family of independent privately held financial services firms, including Stephens Europe Limited, which is authorized and regulated by the Financial Conduct Authority (Registered office 36-38 Cornhill, London, EC3V 3NG, Registered number 8817024) and Stephens Inc. which is regulated by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority (Home Office: 111 Center Street, Little Rock, AR USA, 501-377-2000). Stephens Inc. is a member of NYSE and SIPC. For more information, visit www.stephens.com. © 2020 Stephens